TY - JOUR
T1 - Structural white matter networks in myotonic dystrophy type 1
AU - van Dorst, Maud
AU - Okkersen, Kees
AU - Kessels, Roy P. C.
AU - Meijer, Frederick J. A.
AU - Monckton, Darren G.
AU - van Engelen, Baziel G. M.
AU - Tuladhar, Anil M.
AU - Raaphorst, Joost
AU - Nikolaus, Stephanie
AU - Cornelissen, Yvonne
AU - van Nimwegen, Marlies
AU - Maas, Daphne
AU - Klerks, Ellen
AU - Bouman, Sacha
AU - Knoop, Hans
AU - Heskamp, Linda
AU - Heerschap, Arend
AU - Rahmadi, Ridho
AU - Groot, Perry
AU - Heskes, Tom
AU - Kapusta, Katarzyna
AU - Glennon, Jeffrey
AU - Abghari, Shaghayegh
AU - Aschrafi, Armaz
AU - Poelmans, Geert
AU - Lochmueller, Hanns
AU - Gorman, Grainne
AU - Moreno, Aura Cecilia Jimenez
AU - Trenell, Michael
AU - van Laar, Sandra
AU - Wood, Libby
AU - Cassidy, Sophie
AU - Newman, Jane
AU - Charman, Sarah
AU - Steffaneti, Renae
AU - Taylor, Louise
AU - Brownrigg, Allan
AU - Day, Sharon
AU - Atalaia, Antonio
AU - Schoser, Benedikt
AU - Wenninger, Stephan
AU - Schueller, Angela
AU - Stahl, Kristina
AU - Kuenzel, Heike
AU - Wolf, Martin
AU - Jelinek, Anna
AU - Bassez, Guillaume
AU - Daidj, Ferroudja
AU - Faber, Catharina
AU - Merkies, Ingemar
AU - OPTIMISTIC Consortium
N1 - Funding Information:
Funded by the European Community's Seventh Framework Programme ( FP7/2007–2013 ; grant agreement n° 305697) and the Marigold Foundation. The funders of this trial had no role in the study design, data collection, analysis, interpretation of data, writing the report, or decisions regarding when to submit publications.
Funding Information:
Dr. Tuladhar reports grants from Junior Staff Member Dutch Heart Foundation 2016 T044.
Funding Information:
Ms. van Dorst has no competing interests to disclose; Mr. Okkersen has no competing interests to disclose; Dr. Meijer has no competing interests to disclose; Professor Kessels has no competing interests to disclose; Professor Monckton has been a paid scientific consultant and/or received an honoraria from Biogen Idec, AMO Pharma, Charles River and Vertex Pharmaceuticals. Professor Monckton also had a research contract with AMO Pharma and has received awards from the European Union, Muscular Dystrophy UK and the Myotonic Dystrophy Support Group; Professor Van Engelen reports grant support from the European Union FP-7 program (OPTIMISTIC) and Marigold Foundation; Dr. Tuladhar reports grants from Junior Staff Member Dutch Heart Foundation 2016 T044; Dr. Raaphorst reports grant support from the Marigold Foundation.
Funding Information:
Professor Van Engelen reports grant support from the European Union FP-7 program (OPTIMISTIC) and Marigold Foundation.
Funding Information:
The myriad of neuropsychiatric manifestations reported in myotonic dystrophy type 1 may have its origin in alterations of complex brain network interactions at the structural level. In this study, we tested the hypothesis that altered white matter microstructural integrity and network organisation were present in a cohort of individuals with DM1 compared to unaffected controls, which was expected to be associated with CNS related disease manifestations of DM1. We performed a cross-sectional neuropsychological assessment and brain MRI in 25 myotonic dystrophy type 1 (DM1) patients and 26 age, sex and educational level matched unaffected controls. Patients were recruited from the Dutch cohort of the OPTIMISTIC study, a concluded trial which had included ambulant, genetically confirmed DM1 patients who were severely fatigued. We applied graph theoretical analysis on structural networks derived from diffusion tensor imaging (DTI) data and deterministic tractography to determine global and local network properties and performed group-wise comparisons. Furthermore, we analysed the following variables from structural MRI imaging: semi-quantitative white matter hyperintensity load andwhite matter tract integrity using tract-based spatial statistics (TBSS). Structural white matter networks in DM1 were characterised by reduced global efficiency, local efficiency and strength, while the network density was compatible to controls. Other findings included increased white matter hyperintensity load, and diffuse alterations of white matter microstructure in projection, association and commissural fibres. DTI and network measures were associated (partial correlations coefficients ranging from 0.46 to 0.55) with attention (d2 Test), motor skill (Purdue Pegboard test) and visual-constructional ability and memory (copy subtest of the Rey-Osterrieth Complex Figure Test). DTI and network measures were not associated with clinical measures of fatigue (checklist individual strength, fatigue subscale) or apathy (apathy evaluation scale ? clinician version). In conclusion, our study supports the view of brain involvement in DM1 as a complex network disorder, characterised by white matter network alterations that may have relevant neuropsychological correlations. This work was supported by the European Community's Seventh Framework Programme (FP7/2007?2013; grant agreement n? 305,697) and the Marigold Foundation.Funded by the European Community's Seventh Framework Programme (FP7/2007?2013; grant agreement n? 305697) and the Marigold Foundation. The funders of this trial had no role in the study design, data collection, analysis, interpretation of data, writing the report, or decisions regarding when to submit publications.Professor Monckton has been a paid scientific consultant and/or received an honoraria from Biogen Idec, AMO Pharma, Charles River and Vertex Pharmaceuticals. Professor Monckton also had a research contract with AMO Pharma and has received awards from the European Union, Muscular Dystrophy UK and the Myotonic Dystrophy Support Group.Dr. Tuladhar reports grants from Junior Staff Member Dutch Heart Foundation 2016?T044.
Funding Information:
Professor Monckton has been a paid scientific consultant and/or received an honoraria from Biogen Idec , AMO Pharma, Charles River and Vertex Pharmaceuticals . Professor Monckton also had a research contract with AMO Pharma and has received awards from the European Union, Muscular Dystrophy UK and the Myotonic Dystrophy Support Group.
Publisher Copyright:
© 2018 The Authors
PY - 2019
Y1 - 2019
N2 - The myriad of neuropsychiatric manifestations reported in myotonic dystrophy type 1 may have its origin in alterations of complex brain network interactions at the structural level. In this study, we tested the hypothesis that altered white matter microstructural integrity and network organisation were present in a cohort of individuals with DM1 compared to unaffected controls, which was expected to be associated with CNS related disease manifestations of DM1. We performed a cross-sectional neuropsychological assessment and brain MRI in 25 myotonic dystrophy type 1 (DM1) patients and 26 age, sex and educational level matched unaffected controls. Patients were recruited from the Dutch cohort of the OPTIMISTIC study, a concluded trial which had included ambulant, genetically confirmed DM1 patients who were severely fatigued. We applied graph theoretical analysis on structural networks derived from diffusion tensor imaging (DTI) data and deterministic tractography to determine global and local network properties and performed group-wise comparisons. Furthermore, we analysed the following variables from structural MRI imaging: semi-quantitative white matter hyperintensity load and white matter tract integrity using tract-based spatial statistics (TBSS). Structural white matter networks in DM1 were characterised by reduced global efficiency, local efficiency and strength, while the network density was compatible to controls. Other findings included increased white matter hyperintensity load, and diffuse alterations of white matter microstructure in projection, association and commissural fibres. DTI and network measures were associated (partial correlations coefficients ranging from 0.46 to 0.55) with attention (d2 Test), motor skill (Purdue Pegboard test) and visual-constructional ability and memory (copy subtest of the Rey-Osterrieth Complex Figure Test). DTI and network measures were not associated with clinical measures of fatigue (checklist individual strength, fatigue subscale) or apathy (apathy evaluation scale - clinician version). In conclusion, our study supports the view of brain involvement in DM1 as a complex network disorder, characterised by white matter network alterations that may have relevant neuropsychological correlations. This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013; grant agreement n degrees 305,697) and the Marigold Foundation.
AB - The myriad of neuropsychiatric manifestations reported in myotonic dystrophy type 1 may have its origin in alterations of complex brain network interactions at the structural level. In this study, we tested the hypothesis that altered white matter microstructural integrity and network organisation were present in a cohort of individuals with DM1 compared to unaffected controls, which was expected to be associated with CNS related disease manifestations of DM1. We performed a cross-sectional neuropsychological assessment and brain MRI in 25 myotonic dystrophy type 1 (DM1) patients and 26 age, sex and educational level matched unaffected controls. Patients were recruited from the Dutch cohort of the OPTIMISTIC study, a concluded trial which had included ambulant, genetically confirmed DM1 patients who were severely fatigued. We applied graph theoretical analysis on structural networks derived from diffusion tensor imaging (DTI) data and deterministic tractography to determine global and local network properties and performed group-wise comparisons. Furthermore, we analysed the following variables from structural MRI imaging: semi-quantitative white matter hyperintensity load and white matter tract integrity using tract-based spatial statistics (TBSS). Structural white matter networks in DM1 were characterised by reduced global efficiency, local efficiency and strength, while the network density was compatible to controls. Other findings included increased white matter hyperintensity load, and diffuse alterations of white matter microstructure in projection, association and commissural fibres. DTI and network measures were associated (partial correlations coefficients ranging from 0.46 to 0.55) with attention (d2 Test), motor skill (Purdue Pegboard test) and visual-constructional ability and memory (copy subtest of the Rey-Osterrieth Complex Figure Test). DTI and network measures were not associated with clinical measures of fatigue (checklist individual strength, fatigue subscale) or apathy (apathy evaluation scale - clinician version). In conclusion, our study supports the view of brain involvement in DM1 as a complex network disorder, characterised by white matter network alterations that may have relevant neuropsychological correlations. This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013; grant agreement n degrees 305,697) and the Marigold Foundation.
KW - Myotonic dystrophy type 1
KW - MRI
KW - White matter
KW - Diffusion tensor imaging
KW - Networks
KW - QUALITY-OF-LIFE
KW - COGNITIVE IMPAIRMENT
KW - SPATIAL STATISTICS
KW - BRAIN CONNECTIVITY
KW - CTG REPEATS
KW - RICH-CLUB
KW - SCALE
KW - ABNORMALITIES
KW - PERSONALITY
KW - EXPANSION
U2 - 10.1016/j.nicl.2018.101615
DO - 10.1016/j.nicl.2018.101615
M3 - Article
C2 - 30522973
SN - 2213-1582
VL - 21
SP - 1
EP - 10
JO - NeuroImage: Clinical
JF - NeuroImage: Clinical
M1 - 101615
ER -